Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Chronic myeloid leukemia.

Sawyers CL.

N Engl J Med. 1999 Apr 29;340(17):1330-40. Review. No abstract available.

PMID:
10219069
2.

[Chronic myeloid leukemia: progress and prospects].

Baccarani M, Russo D, Fanin R.

Haematologica. 1991 Jun;76 Suppl 3:40-5. Review. Italian. No abstract available.

PMID:
1752539
3.

[Chronic myeloid leukemia. New prospects for marrow autotransplantation].

Carella AM, Carlier P, Nati S, Congiu A, Pierluigi D, Raffo MR.

Haematologica. 1991 Jun;76 Suppl 3:337-51. Review. Italian. No abstract available.

PMID:
1684348
4.

Treatment of chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation: the case for giving interferon.

Steegmann JL, Casado F, Granados E, Fernández Rañada JM.

Blood. 1998 Apr 1;91(7):2617-8. No abstract available.

5.

Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.

Heimpel H, Allan NC, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J.

Bone Marrow Transplant. 1996 May;17 Suppl 3:S39. No abstract available.

PMID:
8769699
6.
7.

Autologous transplantation therapy for chronic myelogenous leukemia.

Bhatia R, Verfaillie CM, Miller JS, McGlave PB.

Blood. 1997 Apr 15;89(8):2623-34. Review. No abstract available.

8.

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.

Martinelli G, Testoni N, Amabile M, Bonifazi F, De Vivo A, Farabegoli P, Terragna C, Montefusco V, Ottaviani E, Saglio G, Russo D, Baccarani M, Rosti G, Tura S.

Bone Marrow Transplant. 2000 Apr;25(7):729-36.

9.

Chronic myeloid leukemia--advances in biology and new approaches to treatment.

Goldman JM, Melo JV.

N Engl J Med. 2003 Oct 9;349(15):1451-64. Review. No abstract available.

PMID:
14534339
10.
11.

[Therapy of chronic myeloid leukemia].

Freund M.

Internist (Berl). 1993 Jun;34(6):542-9. Review. German. No abstract available.

PMID:
8335444
12.

Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.

Mughal TI, Goldman JM.

Eur J Cancer. 2001 Mar;37(5):561-8. Review. No abstract available.

PMID:
11290430
13.

[Interferon and chronic myeloid leukemia].

Steegmann JL, Pérez Sánchez M, Fernández-Rañada JM.

Sangre (Barc). 1990 Jun;35(3):213-7. Review. Spanish. No abstract available.

PMID:
2204124
14.

[The assessment of therapeutic success in chronic myeloid leukemia].

Griesshammer M, Hehlmann R, Heimpel H.

Dtsch Med Wochenschr. 1995 Apr 28;120(17):620-5. Review. German. No abstract available.

PMID:
7537652
15.

Chronic myelogenous leukemia--update and future directions.

Kantarjian HM, Deisseroth A, Talpaz M.

Rev Invest Clin. 1994 Apr;Suppl:118-24. Review. No abstract available.

PMID:
7886295
16.
17.

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.

Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.

Eur J Haematol. 2003 Apr;70(4):235-9.

PMID:
12656747
18.

BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-alpha.

Reiter A, Marley SB, Hochhaus A, Sohal J, Raanani P, Hehlmann R, Gordon MY, Goldman JM, Cross NC.

Br J Haematol. 1998 Sep;102(5):1271-8.

PMID:
9753056
19.

New directions for the treatment of chronic myeloid leukaemia.

Goldman JM.

Drugs. 1995 May;49(5):651-5. Review. No abstract available.

PMID:
7601007
20.

Supplemental Content

Support Center